Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × cemiplimab × Gynecologic × Clear all

Phase

Status

Recruiting 5 Completed 3 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 9 Tumor-Agnostic 2 Genitourinary 2 Gastrointestinal 2 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Vulvar Neoplasms 1

Interventions

Paclitaxel 21 Carboplatin 14 Cisplatin 12 Bevacizumab 11 fluzoparib 7 Brachytherapy 7 pembrolizumab 6 Drug Therapy 6 apatinib 5 Radiotherapy 5 Injections 5 lenvatinib 4 famitinib 4 Topotecan 4 Tirzepatide 4 Platinum 4 Observation 4 Neoadjuvant Therapy 4 toripalimab 3 olaparib 3 envafolimab 3 dostarlimab 3 camrelizumab 3 Platinum Compounds 3 Megestrol Acetate 3 zimberelimab 2 tislelizumab 2 sintilimab 2 niraparib 2 nimotuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡